• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

估算韩国女性骨质疏松症诊断和治疗改善的未来临床和经济效益:2020 年至 2040 年的模拟预测模型。

Estimating the future clinical and economic benefits of improving osteoporosis diagnosis and treatment among women in South Korea: a simulation projection model from 2020 to 2040.

机构信息

BluePath Solutions, Inc., Los Angeles, CA, USA.

Department of Orthopaedic Surgery, Gangnam Severance Hospital, Yonsei University, Seoul, South Korea.

出版信息

Arch Osteoporos. 2021 Jul 28;16(1):115. doi: 10.1007/s11657-021-00952-3.

DOI:10.1007/s11657-021-00952-3
PMID:34318372
Abstract

UNLABELLED

Using a microsimulation model, the impact of increased diagnosis and treatment of postmenopausal women with osteoporosis on anticipated reduction in fractures and associated costs in South Korea from 2020 to 2040 was projected.

INTRODUCTION

The economic burden of osteoporosis was US $5.1B in 2011 in South Korea. Osteoporosis is expected to strain resources in South Korea as the population most susceptible to osteoporotic fracture, females > 50 years old, is projected to increase by 32% from 2020 to 2040.

METHODS

A microsimulation model was developed to project annual incidence and costs of osteoporotic fractures among postmenopausal women from 2020 to 2040. Fracture risk was estimated using the simplified Fracture Risk Assessment Tool (FRAX). The fracture estimates were based on annualized FRAX risk and impact of treatment. Korean National Health Insurance data informed treatment and case-finding rates in the reference case. Two scenarios were evaluated: 50% increases to (i) case finding (screening rate and subsequent treatment rate) and (ii) treatment rate among those at highest risk.

RESULTS

Among individuals modeled in the reference case from 2020 to 2040, 41.2 M fractures at a cost of US $263.6B were projected. Increased treatment scenario prevented 4.4 M fractures and saved US $13.5B. Increased case-finding scenario prevented 4.0 M fractures and saved US $11.1B.

CONCLUSION

Implementation of policies to enable increasing case finding or treatment may result in fewer fractures and substantial cost savings across the healthcare system. These results highlight the importance of early screening, diagnosis, and preventive treatment.

摘要

目的

使用微观模拟模型,预测 2020 年至 2040 年韩国因增加对绝经后骨质疏松症患者的诊断和治疗而预期减少骨折数量及其相关成本。

简介

2011 年,骨质疏松症给韩国带来的经济负担为 51 亿美元。预计骨质疏松症将给韩国的医疗资源带来压力,因为最易发生骨质疏松性骨折的人群(女性>50 岁)预计将从 2020 年到 2040 年增加 32%。

方法

开发了一个微观模拟模型,以预测 2020 年至 2040 年绝经后妇女骨质疏松性骨折的年发生率和成本。使用简化骨折风险评估工具(FRAX)估计骨折风险。骨折估计数基于年化 FRAX 风险和治疗效果。韩国国家健康保险数据为参考案例中的治疗和发现病例率提供了信息。评估了两种情况:(i)发现病例(筛查率和随后的治疗率)和(ii)高危人群的治疗率增加 50%。

结果

在参考案例中,从 2020 年到 2040 年建模的个体中,预计会发生 4120 万次骨折,费用为 2636 亿美元。增加治疗方案可预防 440 万次骨折,节省 135 亿美元。增加发现病例方案可预防 400 万次骨折,节省 111 亿美元。

结论

实施政策以提高发现病例或治疗的能力可能会减少整个医疗保健系统的骨折数量并节省大量成本。这些结果强调了早期筛查、诊断和预防性治疗的重要性。

相似文献

1
Estimating the future clinical and economic benefits of improving osteoporosis diagnosis and treatment among women in South Korea: a simulation projection model from 2020 to 2040.估算韩国女性骨质疏松症诊断和治疗改善的未来临床和经济效益:2020 年至 2040 年的模拟预测模型。
Arch Osteoporos. 2021 Jul 28;16(1):115. doi: 10.1007/s11657-021-00952-3.
2
Estimating the future clinical and economic benefits of improving osteoporosis diagnosis and treatment among women in China: a simulation projection model from 2020 to 2040.估算改善中国女性骨质疏松症诊断和治疗的未来临床和经济效益:2020 年至 2040 年的模拟预测模型。
Arch Osteoporos. 2021 Aug 2;16(1):118. doi: 10.1007/s11657-021-00958-x.
3
Estimating the future clinical and economic benefits of improving osteoporosis diagnosis and treatment among women in Japan: a simulation projection model from 2020 to 2040.评估改善日本女性骨质疏松症诊断与治疗的未来临床和经济效益:2020年至2040年的模拟预测模型
Arch Osteoporos. 2021 Oct 12;16(1):156. doi: 10.1007/s11657-021-01019-z.
4
Estimating the future clinical and economic benefits of improving osteoporosis diagnosis and treatment among postmenopausal women across eight European countries.估算改善 8 个欧洲国家绝经后妇女骨质疏松症诊断和治疗的未来临床和经济效益。
Arch Osteoporos. 2023 May 16;18(1):68. doi: 10.1007/s11657-023-01230-0.
5
Percentage of the population at high risk of osteoporotic fracture in South Korea: analysis of the 2010 Fifth Korean National Health and Nutrition Examination survey data.韩国骨质疏松性骨折高风险人群比例:基于2010年第五次韩国全国健康与营养检查调查数据的分析
Osteoporos Int. 2014 Apr;25(4):1313-9. doi: 10.1007/s00198-013-2595-z. Epub 2013 Dec 18.
6
The health and economic burden of osteoporotic fractures in Singapore and the potential impact of increasing treatment rates through more pharmacological options.新加坡骨质疏松性骨折的健康和经济负担,以及通过更多药物选择增加治疗率的潜在影响。
Arch Osteoporos. 2019 Nov 26;14(1):114. doi: 10.1007/s11657-019-0664-4.
7
Predicting the intervention threshold for initiating osteoporosis treatment among postmenopausal women in China: a cost-effectiveness analysis based on real-world data.预测中国绝经后妇女开始骨质疏松治疗的干预阈值:基于真实世界数据的成本效益分析。
Osteoporos Int. 2020 Feb;31(2):307-316. doi: 10.1007/s00198-019-05173-6. Epub 2019 Nov 21.
8
Projection of osteoporosis-related fractures and costs in China: 2010-2050.中国2010 - 2050年骨质疏松相关骨折及成本预测
Osteoporos Int. 2015 Jul;26(7):1929-37. doi: 10.1007/s00198-015-3093-2. Epub 2015 Mar 12.
9
Understanding the long-term impact of incident osteoporotic fractures on healthcare utilization and costs in Korean postmenopausal women.了解偶发性骨质疏松性骨折对韩国绝经后女性医疗保健利用和成本的长期影响。
Osteoporos Int. 2024 Feb;35(2):339-352. doi: 10.1007/s00198-023-06934-0. Epub 2023 Oct 25.
10
Screening for and treatment of osteoporosis: construction and validation of a state-transition microsimulation cost-effectiveness model.骨质疏松症的筛查与治疗:状态转换微观模拟成本效益模型的构建与验证
Osteoporos Int. 2015 May;26(5):1477-89. doi: 10.1007/s00198-014-2999-4. Epub 2015 Jan 8.

引用本文的文献

1
Burden of Disease and Treatment Gap in Patients with an Osteoporotic Hip Fracture between 2015 and 2019 in Italy.2015年至2019年意大利骨质疏松性髋部骨折患者的疾病负担与治疗差距
Drugs Aging. 2025 Jul;42(7):643-653. doi: 10.1007/s40266-025-01211-7. Epub 2025 Jun 2.
2
Estimating the future clinical and economic benefits of improving osteoporosis diagnosis and treatment among postmenopausal women across eight European countries.估算改善 8 个欧洲国家绝经后妇女骨质疏松症诊断和治疗的未来临床和经济效益。
Arch Osteoporos. 2023 May 16;18(1):68. doi: 10.1007/s11657-023-01230-0.
3
Quality improvement initiatives in the care and prevention of fragility fractures in the Asia Pacific region.

本文引用的文献

1
Prevalence and Cost of Subsequent Fractures Among U.S. Patients with an Incident Fracture.美国初次骨折患者后续骨折的发生率和成本。
J Manag Care Spec Pharm. 2017 Apr;23(4):461-471. doi: 10.18553/jmcp.2017.23.4.461.
2
[Late results following hip injuries in childhood].
Z Orthop Ihre Grenzgeb. 1969 Jul;106(3):609-22.
亚太地区脆性骨折护理和预防的质量改进措施。
Arch Osteoporos. 2022 Aug 20;17(1):115. doi: 10.1007/s11657-022-01153-2.
4
Cost-Effectiveness of Denosumab for the Treatment of Postmenopausal Osteoporosis in South Korea.地诺单抗治疗韩国绝经后骨质疏松症的成本效益
J Bone Metab. 2022 May;29(2):83-92. doi: 10.11005/jbm.2022.29.2.83. Epub 2022 May 31.
5
Harmonization of Osteoporosis Guidelines: Paving the Way for Disrupting the Status Quo in Osteoporosis Management in the Asia Pacific.骨质疏松症指南的协调统一:为打破亚太地区骨质疏松症管理的现状铺平道路。
J Bone Miner Res. 2022 Apr;37(4):608-615. doi: 10.1002/jbmr.4544. Epub 2022 Apr 3.